Supplementary Table S2 from Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer

Abstract
Indications and characteristics of probiotic CBT in NSCLC patients (N=39).